InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by IWAKI YUICHI, Chairman & CEO. Director active across 2 companies, notably MEDICINOVA INC. Cumulatively, 2 reports have been recorded. History available since 9 July 2021. The latest transaction was disclosed on 9 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Yuichi Iwaki is the President and CEO of Medicinova Inc. He is responsible for the strategic direction of the company, focused on developing innovative treatments for neurological diseases. His leadership is crucial to Medicinova's mission of improving patients' lives.